Saliwanchik, Lloyd & Eisenschenk

Saliwanchik, Lloyd & Eisenschenk (SLE) is an established intellectual property boutique law firm with its headquarters in Gainesville, Florida. Founded in 1981, the firm has over 40 years of experience in securing U.S. and international patent and trademark protection for a diverse client base, ranging from individual innovators to large corporations and research institutions globally. The firm comprises seventeen IP professionals, with many holding advanced technical degrees and eight attorneys board-certified in Intellectual Property Law by the Florida Bar. SLE is recognized in Martindale-Hubbell's Bar Register of Preeminent Lawyers and has been ranked by Harrity Patent Analytics and Patent Bots for its patent prosecution volume and quality. BCGSearch.com also lists the firm in Tier 3 for Intellectual Property in Gainesville.

SLE's IP litigation and counseling practice spans a broad range of technology areas. Historically, the firm pioneered biotechnology and pharmaceutical patent law, notably arguing the first successful appellate court case affirming the patentability of a living microorganism (In re Bergy). Currently, their expertise extends to pharmaceuticals, biotechnology, medical and industrial instruments, organic chemistry, electronics, software, optics, materials science, mechanical devices, agriculture, and genomics. The firm provides a full suite of services, including patentability, infringement, and validity opinions, as well as negotiating licensing and contract arrangements and advising on intellectual property dispute settlements.

Based on available tracking, Saliwanchik, Lloyd & Eisenschenk has appeared as lead counsel in one tracked case, representing the defendant. This suggests a practice that includes defending operating companies in patent infringement actions. The firm's website highlights its experience in representing clients whose patent applications have become involved in appellate proceedings and advising on the settlement of intellectual property disputes. While the specific details or outcomes of the "Untitled case" in the provided internal data are not publicly available through general web searches, the firm's broader profile indicates a focus on securing and defending intellectual property rights.

The firm also possesses extensive experience in post-issuance patent practice before the U.S. Patent and Trademark Office (USPTO). This includes navigating procedures available for challenging the validity of issued patents before the Patent Trial and Appeal Board (PTAB) through inter partes review (IPR) and post-grant review (PGR), as well as for patent owners seeking to strengthen or correct their patent scope. The firm's attorneys leverage both patent prosecution and litigation experience to develop strategic post-grant approaches for their clients.

Key partners in the firm's intellectual property practice include shareholders Christopher Eisenschenk, Louis C. Frank, Jeff Lloyd, and David R. Saliwanchik, along with partners Justin Y. Gao and Cari C. Massengill. While the internal case data lists Bruce Morris as lead counsel, public records indicate that Bruce F. Morriss, an IP litigation attorney, passed away in 2018 and was associated with a different firm at that time, suggesting this information in the internal data may be outdated.